Grundinformationen
- Standard-SMILES
CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O- InChIKey
BHMBVRSPMRCCGG-OUTUXVNYSA-N- Summenformel
- C20H32O5
- Durchschnittliche Molmasse
- 352,5 g/mol
- Monoisotopische Masse
- 352,22497412
Namen und Bezeichner
- Bevorzugter Name
- Prostaglandin D2
- IUPAC
- (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
41598-07-6- PubChem CID
- 448457
- DTXSID
DTXSID30897162- ChEMBL
CHEMBL1235252- ChEBI
CHEBI:15555- UNII
- RXY07S6CZ2
- EC Number
- 636-995-9
- Nikkaji
- J16.416J
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,6
- Polarare Oberfläche (TPSA)
- 94,8 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 12
- Schwere Atome
- 25
- Formalladung
- 0
- Komplexität
- 469
Experimentelle und physikochemische Eigenschaften
Collision Cross Section
196.63 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]
192.4 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)];186.17 Ų [M-H2O-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
189.4 Ų [M-H]-;195.4 Ų [M+Na]+
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Chemie und Industrie
Pharmakologische Informationen
Metabolite Pathways
Acetaminophen Action Pathway;Acetylsalicylic Acid Action Pathway;Antipyrine Action Pathway;Antrafenine Action Pathway;Arachidonic Acid Metabolism;Bromfenac Action Pathway;Carprofen Action Pathway;Celecoxib Action Pathway;Diclofenac Action Pathway;Diflunisal Action Pathway;Total 43 pathways, visit the HMDB page for details
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…